Top compounds associated with response to RABL6


Feature Type Standardized
Nominal ANOVA
mRNA rigosertib CTRPv2 pan-cancer AAC 0.043 0.2
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.049 0.2
mRNA BMS-536924 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA I-BET151 CTRPv2 pan-cancer AAC 0.04 0.2
mRNA palmostatin B CTRPv2 pan-cancer AAC -0.058 0.2
mRNA CHIR-99021 CTRPv2 pan-cancer AAC 0.044 0.2
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.049 0.2
mRNA BRD-K33199242 CTRPv2 pan-cancer AAC 0.049 0.2
mRNA BRD-K24690302 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA Erlotinib FIMM pan-cancer AAC 0.22 0.2
Download CSV